Cargando…
SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19
RATIONALE & OBJECTIVE: A number of serologic tests for immunoglobulin G (IgG) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are now commercially available, including multiple lateral flow immunoassays (LFIAs), which have the advantage of being inexpensive and easy to use,...
Autores principales: | Prendecki, Maria, Clarke, Candice, McKinnon, Tom, Lightstone, Liz, Pickering, Matthew C., Thomas, David C., McAdoo, Stephen P., Willicombe, Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834810/ https://www.ncbi.nlm.nih.gov/pubmed/33521621 http://dx.doi.org/10.1016/j.xkme.2020.09.010 |
Ejemplares similares
-
COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021) -
Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era
por: Clarke, Candice, et al.
Publicado: (2020) -
Severe COVID‐19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis
por: Mobayen, Golzar, et al.
Publicado: (2021) -
Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2021) -
Anti–glomerular basement membrane disease during the COVID-19 pandemic
por: Prendecki, Maria, et al.
Publicado: (2020)